NO972892L - Bicyclic Low Molecular Weight Thrombin Inhibitors - Google Patents
Bicyclic Low Molecular Weight Thrombin InhibitorsInfo
- Publication number
- NO972892L NO972892L NO972892A NO972892A NO972892L NO 972892 L NO972892 L NO 972892L NO 972892 A NO972892 A NO 972892A NO 972892 A NO972892 A NO 972892A NO 972892 L NO972892 L NO 972892L
- Authority
- NO
- Norway
- Prior art keywords
- bicyclic
- molecular weight
- low molecular
- thrombin inhibitors
- weight thrombin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Foreliggende oppfinnelse angår heterocykliske, kompetitive inhibitorer av enzymet trombin, fremstilling av (dem og farmasøytiske preparater derav. Oppfinnelsen angår også anvendelse av slike forbindelser og preparater in vitro som antikoaguleringsmidler og in vivo som midler for befiandling og profylakse av trombotiske lidelser så som venøs trombose, lungeemboli og arterien trombose som er et resultat av akutte ischemi, så som myokardialt infarkt eller cerebralt infarkt. Disse forbindelsene og preparatene er videre terapeutisk nyttige for forhindring og behandling av koagulopatier knyttet til hjerte-bypass-operasjoner så vel som restenose etter transluminal angioplasti.This invention also relates to the use of such compounds and preparations in vitro as anticoagulants and in vivo as agents for the prophylaxis and prophylaxis of thrombotic disorders such as venous thrombosis. pulmonary embolism and artery thrombosis resulting from acute ischemia such as myocardial infarction or cerebral infarction.These compounds and preparations are therapeutically useful for the prevention and treatment of coagulopathies associated with cardiac bypass surgery as well as restenosis after transluminal angioplasty.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9426038.7A GB9426038D0 (en) | 1994-12-22 | 1994-12-22 | Low molecular weight bicyclic thrombin inhibitors |
GBGB9503136.5A GB9503136D0 (en) | 1994-12-22 | 1995-02-17 | Low molecular weight bicyclic thrombin inhibitors |
GBGB9510267.9A GB9510267D0 (en) | 1995-05-22 | 1995-05-22 | Low molecular weight thiobicyclic thrombin inhibitors |
GBGB9510265.3A GB9510265D0 (en) | 1995-05-22 | 1995-05-22 | Low molecular weight diaminobicyclic thrombin inhibitors |
GBGB9510266.1A GB9510266D0 (en) | 1995-05-22 | 1995-05-22 | Low molecular weight bicyclic thrombin inhibitors |
PCT/CA1995/000708 WO1996019483A1 (en) | 1994-12-22 | 1995-12-21 | Low molecular weight bicyclic thrombin inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
NO972892D0 NO972892D0 (en) | 1997-06-20 |
NO972892L true NO972892L (en) | 1997-08-20 |
Family
ID=27517273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO972892A NO972892L (en) | 1994-12-22 | 1997-06-20 | Bicyclic Low Molecular Weight Thrombin Inhibitors |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP0802916A1 (en) |
JP (1) | JPH11508535A (en) |
CN (1) | CN1175259A (en) |
AP (1) | AP9701004A0 (en) |
AU (2) | AU4250596A (en) |
BG (1) | BG101647A (en) |
CA (1) | CA2208772A1 (en) |
CZ (1) | CZ189997A3 (en) |
EE (1) | EE9700113A (en) |
FI (1) | FI972466A (en) |
HU (1) | HUT77651A (en) |
IL (1) | IL116503A0 (en) |
IS (1) | IS4504A (en) |
LV (1) | LV12019B (en) |
MD (1) | MD970253A (en) |
MX (1) | MX9704718A (en) |
NO (1) | NO972892L (en) |
NZ (1) | NZ297360A (en) |
OA (1) | OA10493A (en) |
PL (1) | PL320965A1 (en) |
SK (1) | SK83897A3 (en) |
WO (1) | WO1996019483A1 (en) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6020331A (en) | 1995-03-24 | 2000-02-01 | Molecumetics, Ltd. | β-sheet mimetics and use thereof as protease inhibitors |
US6699869B1 (en) | 1995-03-24 | 2004-03-02 | Myriad Genetics Inc. | β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins |
US6245764B1 (en) | 1995-03-24 | 2001-06-12 | Molecumetics Ltd. | β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins |
IT1277405B1 (en) * | 1995-08-01 | 1997-11-10 | Menarini Farma Ind | BICYCLIC LACTAM DERIVATIVES AS THROMBIN INHIBITORS |
IL119466A (en) | 1995-11-03 | 2001-08-26 | Akzo Nobel Nv | Thrombin inhibitors, their preparation and pharmaceutical compositions containing them |
CA2246256A1 (en) * | 1996-02-13 | 1997-08-21 | Akzo Nobel Nv | Serine protease inhibitors |
TW442452B (en) | 1996-03-01 | 2001-06-23 | Akzo Nobel Nv | Serine protease inhibitors having an alkynylamino side chain |
IL120311A (en) * | 1996-03-01 | 2001-10-31 | Akzo Nobel Nv | Serine protease inhibitors and pharmaceutical compositions containing them |
AU3232597A (en) * | 1996-06-18 | 1998-01-07 | Warner-Lambert Company | Pyrrolo{1,2-a}pyrazine-1,4-dione serine protease inhibitors |
EP1661566A3 (en) * | 1996-08-05 | 2008-04-16 | Myriad Genetics, Inc. | Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
WO1998005333A1 (en) * | 1996-08-05 | 1998-02-12 | Molecumetics Ltd. | Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
US6117896A (en) | 1997-02-10 | 2000-09-12 | Molecumetics Ltd. | Methods for regulating transcription factors |
AU4172397A (en) * | 1996-09-06 | 1998-03-26 | Biochem Pharma Inc. | Lactam inhibitors of thrombin |
US6369080B2 (en) | 1996-10-11 | 2002-04-09 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
US6262047B1 (en) | 1996-10-11 | 2001-07-17 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
US6063794A (en) | 1996-10-11 | 2000-05-16 | Cor Therapeutics Inc. | Selective factor Xa inhibitors |
US6194435B1 (en) | 1996-10-11 | 2001-02-27 | Cor Therapeutics, Inc. | Lactams as selective factor Xa inhibitors |
AU5526098A (en) * | 1996-12-23 | 1998-07-17 | Biochem Pharma Inc. | Bicyclic thrombin inhibitors |
JP2002514214A (en) | 1997-04-14 | 2002-05-14 | シーオーアール セラピューティクス インコーポレイテッド | Selective factor Xa inhibitor |
CA2285685A1 (en) | 1997-04-14 | 1998-10-22 | Cor Therapeutics, Inc. | Selective factor xa inhibitors |
NZ500351A (en) * | 1997-04-14 | 2001-10-26 | Cor Therapeutics Inc | Cyclic diaza compounds as selective factor Xa inhibitors |
US6228854B1 (en) | 1997-08-11 | 2001-05-08 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
US6218382B1 (en) | 1997-08-11 | 2001-04-17 | Cor Therapeutics, Inc | Selective factor Xa inhibitors |
US6333321B1 (en) | 1997-08-11 | 2001-12-25 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
JP2001517623A (en) * | 1997-09-23 | 2001-10-09 | メルク エンド カムパニー インコーポレーテッド | Thrombin inhibitors |
ES2192764T3 (en) * | 1998-02-12 | 2003-10-16 | Molecumetics Ltd | MIMETICS OF LAMINA BETA AND METHODS RELATED TO THE USE OF THE SAME. |
US6323219B1 (en) | 1998-04-02 | 2001-11-27 | Ortho-Mcneil Pharmaceutical, Inc. | Methods for treating immunomediated inflammatory disorders |
US8106094B2 (en) | 1998-07-06 | 2012-01-31 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for treating skin conditions |
US8093293B2 (en) | 1998-07-06 | 2012-01-10 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin conditions |
AU3127900A (en) | 1998-12-23 | 2000-07-31 | Du Pont Pharmaceuticals Company | Thrombin or factor xa inhibitors |
CA2361479A1 (en) | 1999-01-27 | 2000-08-03 | Ortho-Mcneil Pharmaceutical, Inc. | Peptidyl heterocyclic ketones useful as tryptase inhibitors |
FR2795072B1 (en) * | 1999-06-15 | 2001-07-27 | Adir | NOVEL BICYCLIC DERIVATIVES OF AMINO-PYRAZINONES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
DE60124080T2 (en) * | 2000-03-23 | 2007-03-01 | Elan Pharmaceuticals, Inc., San Francisco | COMPOUNDS AND METHOD FOR THE TREATMENT OF ALZHEIMER'S DISEASE |
WO2002002519A2 (en) * | 2000-06-29 | 2002-01-10 | Bristol-Myers Squibb Pharma Company | THROMBIN OR FACTOR Xa INHIBITORS |
US8431550B2 (en) | 2000-10-27 | 2013-04-30 | Johnson & Johnson Consumer Companies, Inc. | Topical anti-cancer compositions and methods of use thereof |
FR2818277B1 (en) * | 2000-12-14 | 2003-01-24 | Servier Lab | NOVEL BICYCLIC DERIVATIVES OF AMINO-PYRAZINONES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
US7192615B2 (en) | 2001-02-28 | 2007-03-20 | J&J Consumer Companies, Inc. | Compositions containing legume products |
JP2005526722A (en) | 2002-02-14 | 2005-09-08 | ミリアド・ジェネティックス・インコーポレイテッド | β-sheet mimetics and related compositions and methods |
WO2003082197A2 (en) | 2002-03-22 | 2003-10-09 | Gpc Biotech Ag | Immunosuppressant compounds, methods and uses related thereto |
ES2819218T3 (en) | 2014-10-06 | 2021-04-15 | Cortexyme Inc | Gingipain lysine inhibitors |
JO3637B1 (en) | 2015-04-28 | 2020-08-27 | Janssen Sciences Ireland Uc | Rsv antiviral pyrazolo- and triazolo-pyrimidine compounds |
EP3374352A4 (en) | 2015-11-09 | 2019-10-02 | Cortexyme, Inc. | Inhibitors of arginine gingipain |
EP3512846A4 (en) | 2016-09-16 | 2020-06-10 | Cortexyme, Inc. | Ketone inhibitors of lysine gingipain |
TW201932470A (en) | 2017-11-29 | 2019-08-16 | 愛爾蘭商健生科學愛爾蘭無限公司 | Pyrazolopyrimidines having activity against RSV |
KR20200116099A (en) | 2018-01-31 | 2020-10-08 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | Cycloalkyl-substituted pyrazolopyrimidines with activity against RSV |
EP3784667B1 (en) | 2018-04-23 | 2023-08-16 | Janssen Sciences Ireland Unlimited Company | Heteroaromatic compounds having activity against rsv |
-
1995
- 1995-12-21 CN CN95197614A patent/CN1175259A/en active Pending
- 1995-12-21 CA CA002208772A patent/CA2208772A1/en not_active Abandoned
- 1995-12-21 WO PCT/CA1995/000708 patent/WO1996019483A1/en not_active Application Discontinuation
- 1995-12-21 AU AU42505/96A patent/AU4250596A/en not_active Abandoned
- 1995-12-21 PL PL95320965A patent/PL320965A1/en unknown
- 1995-12-21 AP APAP/P/1997/001004A patent/AP9701004A0/en unknown
- 1995-12-21 EE EE9700113A patent/EE9700113A/en unknown
- 1995-12-21 EP EP95940923A patent/EP0802916A1/en not_active Ceased
- 1995-12-21 CZ CZ971899A patent/CZ189997A3/en unknown
- 1995-12-21 JP JP8519383A patent/JPH11508535A/en active Pending
- 1995-12-21 HU HU9800216A patent/HUT77651A/en unknown
- 1995-12-21 NZ NZ297360A patent/NZ297360A/en unknown
- 1995-12-21 SK SK838-97A patent/SK83897A3/en unknown
- 1995-12-21 MD MD97-0253A patent/MD970253A/en unknown
- 1995-12-22 AU AU40628/95A patent/AU715378B2/en not_active Ceased
- 1995-12-22 IL IL11650395D patent/IL116503A0/en unknown
-
1997
- 1997-06-11 IS IS4504A patent/IS4504A/en unknown
- 1997-06-11 FI FI972466A patent/FI972466A/en unknown
- 1997-06-18 OA OA70029A patent/OA10493A/en unknown
- 1997-06-20 BG BG101647A patent/BG101647A/en unknown
- 1997-06-20 NO NO972892A patent/NO972892L/en unknown
- 1997-06-23 MX MX9704718A patent/MX9704718A/en unknown
- 1997-07-15 LV LVP-97-141A patent/LV12019B/en unknown
Also Published As
Publication number | Publication date |
---|---|
MX9704718A (en) | 1998-06-28 |
PL320965A1 (en) | 1997-11-24 |
FI972466A0 (en) | 1997-06-11 |
JPH11508535A (en) | 1999-07-27 |
MD970253A (en) | 1999-05-31 |
CA2208772A1 (en) | 1996-06-27 |
HUT77651A (en) | 1998-07-28 |
EE9700113A (en) | 1997-12-15 |
WO1996019483A1 (en) | 1996-06-27 |
NZ297360A (en) | 2000-03-27 |
AU4062895A (en) | 1996-07-04 |
AP9701004A0 (en) | 1997-07-31 |
AU4250596A (en) | 1996-07-10 |
LV12019A (en) | 1998-04-20 |
CZ189997A3 (en) | 1998-09-16 |
FI972466A (en) | 1997-08-19 |
LV12019B (en) | 1998-07-20 |
IS4504A (en) | 1997-06-11 |
EP0802916A1 (en) | 1997-10-29 |
AU715378B2 (en) | 2000-02-03 |
SK83897A3 (en) | 1998-05-06 |
BG101647A (en) | 1998-03-31 |
OA10493A (en) | 2002-04-10 |
IL116503A0 (en) | 1996-03-31 |
NO972892D0 (en) | 1997-06-20 |
CN1175259A (en) | 1998-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO972892L (en) | Bicyclic Low Molecular Weight Thrombin Inhibitors | |
WO1995018830A3 (en) | Inhibitors of human plasmin derived from the kunitz domains | |
TW372232B (en) | Phenylalanine derivatives | |
NO177785C (en) | Analogous Methods for Preparing Therapeutically Active Alkoxy-4 (1H) -pyridone Derivatives | |
IS2822B (en) | Inhibits human phosphatidyl-inositol 3-kinase delta | |
BG103233A (en) | Heterocyclic thioesters and ketones | |
NO20021281D0 (en) | Wash off investment composition | |
BR9811099A (en) | Urokinase inhibitors | |
EP1126836A4 (en) | Benzamide potassium channel inhibitors | |
WO2004058185A3 (en) | Antiangiogenesis by inhibiting protein kinase ck2 activity | |
de Feyter et al. | Percutaneous transluminal coronary angioplasty for unstable angina | |
WO2000071515A3 (en) | INHIBITORS OF FACTOR Xa | |
NO308897B1 (en) | Benzothiazine dioxides as endothelin antagonists, processes for their preparation, pharmaceutical compositions comprising the compounds, and use of the compounds | |
EP0930067A3 (en) | MMP inhibitors for the treatment of ocular angiogenesis | |
NO177312C (en) | Process for the preparation of delayed effect hirudin derivatives | |
BR0008310A (en) | Alpha-Alanine derivatives | |
AU4124089A (en) | Use of ACE-inhibitor for suppressing the formation of neointima and the reduction of the vascular lumen by vascular wall thickening after vascular damage | |
TW369541B (en) | Thrombin inhibitors | |
DK478585A (en) | 4-ALCOXY-PYRIDO (2,3-D) PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND USE | |
BR0012391A (en) | Diacylhydrazine derivatives | |
FI943850A (en) | 3-alkyloxy, aryloxy or arylalkyloxybenzo (b) thiophene-2-carboxamides as inhibitors of cell adhesion | |
NO20002408L (en) | 5-HT1F antagonists | |
WO1999002565A3 (en) | Agent for the treatment and/or prophylaxis of microcirculation disorders | |
MX9704594A (en) | Heterocyclic keto arginine peptides as thrombin inhibitors. | |
AUPP345098A0 (en) | Novel anti-fibrinolytic agents |